Correlating tau pathology to brain atrophyusing a physics-based Bayesian model
Misfolded tau proteins are a classical hallmark of Alzheimer’s disease. Increasing evidence indicates that tau–and not amyloid–is the main agent in driving neurodegeneration and tissue atrophy in Alzheimer’s brains. However, the precise correlation between tau and atrophy remains insufficiently unde...
Main Authors: | Schafer, A, Chaggar, P, Goriely, A, Kuhl, E |
---|---|
Other Authors: | Alzheimer’s Disease Neuroimaging Initiative |
Format: | Journal article |
Language: | English |
Published: |
Springer
2022
|
Similar Items
-
Predicting brain atrophy from tau pathology: a summary of clinical findings and their translation into personalized models
by: Schäfer, A, et al.
Published: (2021) -
Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
by: Stockman, CA, et al.
Published: (2024) -
PAC1 receptor–mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain
by: Schaler, AW, et al.
Published: (2021) -
Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome
by: Fornari, S, et al.
Published: (2019) -
Protein-protein interactions in neurodegenerative diseases: a conspiracy theory
by: Thompson, T, et al.
Published: (2020)